JP2015529198A5 - - Google Patents

Download PDF

Info

Publication number
JP2015529198A5
JP2015529198A5 JP2015528571A JP2015528571A JP2015529198A5 JP 2015529198 A5 JP2015529198 A5 JP 2015529198A5 JP 2015528571 A JP2015528571 A JP 2015528571A JP 2015528571 A JP2015528571 A JP 2015528571A JP 2015529198 A5 JP2015529198 A5 JP 2015529198A5
Authority
JP
Japan
Prior art keywords
compound
immunogenic carrier
conjugate
protein
nhc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015528571A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015529198A (ja
JP6131415B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/055724 external-priority patent/WO2014031600A1/en
Publication of JP2015529198A publication Critical patent/JP2015529198A/ja
Publication of JP2015529198A5 publication Critical patent/JP2015529198A5/ja
Application granted granted Critical
Publication of JP6131415B2 publication Critical patent/JP6131415B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015528571A 2012-08-21 2013-08-20 イムノアッセイに使用するためのクエチアピンのハプテン Active JP6131415B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261691462P 2012-08-21 2012-08-21
US61/691,462 2012-08-21
PCT/US2013/055724 WO2014031600A1 (en) 2012-08-21 2013-08-20 Haptens of quetiapine for use in immunoassays

Publications (3)

Publication Number Publication Date
JP2015529198A JP2015529198A (ja) 2015-10-05
JP2015529198A5 true JP2015529198A5 (enExample) 2016-04-14
JP6131415B2 JP6131415B2 (ja) 2017-05-24

Family

ID=49081009

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015528571A Active JP6131415B2 (ja) 2012-08-21 2013-08-20 イムノアッセイに使用するためのクエチアピンのハプテン

Country Status (10)

Country Link
US (1) US9304126B2 (enExample)
EP (2) EP3305784B1 (enExample)
JP (1) JP6131415B2 (enExample)
CN (2) CN107266432B (enExample)
AU (2) AU2013305935B2 (enExample)
CA (1) CA2882557C (enExample)
ES (2) ES2645433T3 (enExample)
PL (2) PL3305784T3 (enExample)
PT (2) PT3305784T (enExample)
WO (1) WO2014031600A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6216926B2 (ja) 2012-08-21 2017-10-25 ヤンセン ファーマシューティカ エヌ.ベー. オランザピンに対する抗体及びその使用
CA2882489A1 (en) 2012-08-21 2014-02-27 Ortho-Clinical Diagnostics, Inc. Antibodies to paliperidone haptens and use thereof
EP3305784B1 (en) * 2012-08-21 2020-08-12 Janssen Pharmaceutica NV Haptens of quetiapine for use in immunoassays
CN110054694B (zh) 2012-08-21 2024-02-20 詹森药业有限公司 阿立哌唑半抗原的抗体及其用途
PL3333195T3 (pl) 2012-08-21 2021-02-22 Janssen Pharmaceutica Nv Przeciwciała względem kwetiapiny i ich zastosowania
AU2013305879B2 (en) 2012-08-21 2017-10-12 Saladax Biomedical Inc. Antibodies to aripiprazole and use thereof
US20140057303A1 (en) 2012-08-21 2014-02-27 Janssen Pharmaceutica Nv Antibodies to Olanzapine Haptens and Use Thereof
PL3663317T3 (pl) 2012-08-21 2023-06-05 Janssen Pharmaceutica Nv Przeciwciała skierowane przeciwko haptenom kwetiapinowym i ich zastosowanie
HK1211958A1 (en) 2012-08-21 2016-06-03 Ortho-Clinical Diagnostics, Inc. Antibodies to paliperidone and use thereof
PT3462173T (pt) 2012-08-21 2021-04-28 Janssen Pharmaceutica Nv Anticorpos contra risperidona e utilização dos mesmos
WO2014031645A1 (en) 2012-08-21 2014-02-27 Ortho-Clinical Diagnostics, Inc Antibodies to risperidone haptens and use thereof
PL3321254T3 (pl) 2012-08-21 2021-01-11 Janssen Pharmaceutica Nv Hapteny arypiprazolu i ich zastosowanie w testach immunologicznych
BR112017017719A2 (pt) 2015-02-20 2018-04-10 Idexx Lab Inc imunoensaio homogêneo com compensação para sinal antecedente
AU2016372069A1 (en) 2015-12-17 2018-06-07 Saladax Biomedical Inc. Antibodies to risperidone and use thereof
WO2017106508A1 (en) 2015-12-17 2017-06-22 Janssen Pharmaceutica Nv Antibodies to quetiapine and use thereof
US11422136B2 (en) 2017-10-19 2022-08-23 Idexx Laboratories, Inc. Detection of symmetrical dimethylarginine
EP3934752A1 (en) 2019-03-08 2022-01-12 Mevion Medical Systems, Inc. Delivery of radiation by column and generating a treatment plan therefor
CN111808046B (zh) * 2020-06-30 2022-11-11 杭州同舟生物技术有限公司 一种喹硫平人工半抗原、人工抗原及其制备方法和应用
CN116354904B (zh) * 2023-04-26 2023-08-01 北京丹大生物技术有限公司 一种喹硫平衍生物半抗原、抗原、抗喹硫平抗体及其应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US6034078A (en) 1992-05-29 2000-03-07 Eli Lilly And Company Limited Thienobenzodiazepine compounds
AU668159B2 (en) 1992-05-29 1996-04-26 Lilly Industries Limited Pharmaceutical compounds
US5395933A (en) 1992-08-07 1995-03-07 Eastman Kodak Company Carbamazepine hapten analogues
US6958156B2 (en) 2000-12-15 2005-10-25 Vyrex Corporation Isoflavone derivatives
US7193065B2 (en) * 2001-07-13 2007-03-20 Roche Diagnostics Operations, Inc. Protease inhibitor conjugates and antibodies useful in immunoassay
WO2003082877A1 (en) 2002-03-28 2003-10-09 Eli Lilly And Company Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
DK1546134T3 (da) 2002-08-05 2007-09-10 Lilly Co Eli Piperazinsubstituerede arylbenzodiazepiner
WO2005028458A1 (en) * 2003-09-23 2005-03-31 Fermion Oy Preparation of quetiapine
TW200616604A (en) 2004-08-26 2006-06-01 Nicholas Piramal India Ltd Nitric oxide releasing prodrugs containing bio-cleavable linker
FR2878850B1 (fr) * 2004-12-02 2008-10-31 Cis Bio Internat Sa Derives de l'inositol-1-phosphate
CA2699062A1 (en) * 2007-09-27 2009-04-02 Novartis Ag Drug monitoring assay
US20100069356A1 (en) 2008-09-17 2010-03-18 Auspex Pharmaceuticals, Inc. Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
AU2009305203B2 (en) 2008-10-14 2013-03-07 Entasis Therapeutics Limited Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
EP2194048A1 (en) 2008-12-02 2010-06-09 Dirk Sartor Nitrate esters for the treatment of vascular and metabolic diseases
CA2927380C (en) * 2009-12-31 2017-07-04 Kempharm, Inc. Amino acid conjugates of quetiapine, process for making and using the same
WO2011112657A1 (en) * 2010-03-11 2011-09-15 Kempharm, Inc. Fatty acid conjugates of quetiapine, process for making and using the same
US8088594B2 (en) * 2010-03-16 2012-01-03 Saladax Biomedical Inc. Risperidone immunoassay
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
US8623324B2 (en) 2010-07-21 2014-01-07 Aat Bioquest Inc. Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates
JP5757497B2 (ja) * 2010-10-06 2015-07-29 公立大学法人大阪府立大学 シガトキシン類ctx1bおよび54−デオキシ−ctx1bを認識するモノクローナル抗体およびそれを用いるシガトキシン類検出キット
WO2013088255A1 (en) 2011-12-15 2013-06-20 Alkermes Pharma Ireland Limited Prodrugs of secondary amine compounds
EP3305784B1 (en) * 2012-08-21 2020-08-12 Janssen Pharmaceutica NV Haptens of quetiapine for use in immunoassays

Similar Documents

Publication Publication Date Title
JP2015529197A5 (enExample)
EP4253075A3 (en) N,n'-diarylurea derivative, manufacturing method thereof, and thermosensitive recording material using same
JP2015527363A5 (enExample)
JP2017222671A5 (enExample)
BR112014029578A2 (pt) composto heterocíclico fundido
UY35854A (es) Métodos para la conjugación de oxima con polipéptidos ceto-modificados
AR121291A2 (es) Proceso para la recuperación de un metal de una mena
EA200801372A1 (ru) Способы получения замещенных пиримидинов
BR112015032689A2 (pt) composto heterocíclico fundido e uso em controle de pragas do mesmo
ES2571483T3 (es) Producto intermedio para producir un éster de ácido sulfónico cíclico
NO20084278L (no) Bezothiazol derivatives as beta2 adrenoreceptor agonists
RU2015138503A (ru) Способ экстракции и выделения
IL291939B (en) Methods for the preparation of 5-bromo-2-(3-chloro-pyridin-2-yl)-2h-pyrazole-3-carboxylic acid
EA201070589A1 (ru) Способ получения морфийных соединений
CY1123757T1 (el) Διεργασια για παρασκευη ενωσεων καρβοξαμιδιων ινδολης
EA201201127A1 (ru) Способ получения небиволола
BRPI0606676A2 (pt) processos para a preparação de derivados de ácido 4-(fenóxi-5-metil-pirimidin-4-ilóxi)piperidina-1-carboxì lico e compostos relacionados
BR112017012537A2 (pt) copolímero de álcool polimetalílico e corpo moldado que contém o mesmo e método de produção de copolímero de álcool polimetalílico
PH12015501636B1 (en) Method for preparing 1-(4-(4-(3,4 - dichloro -2- fluorophenylamino)-7- methoxyquinazolin -6- yloxy) piperidin -1-yl) prop-2-en-1-one
WO2013132065A3 (de) Mikromechanisches messelement und verfahren zur herstellung eines mikromechanischen messelements
DK1763586T3 (da) Ny sekvens til forbedring af ekspressionen af nukleinsyre
EA201270390A1 (ru) 1,2,4-триазин, который может быть использован в качестве ускорителя вулканизации, и способ его получения
EA200971019A1 (ru) Способы получения (r)-2-метилпирролидина и (s)-2-метилпирролидина и их солей винной кислоты
EA200900257A1 (ru) Полиморфные формы сульфатов зипразидона
DK1737855T3 (da) Fremgangsmåde til halvsyntese af deserpidin